Industry news
Allergan buys Oculeve for $125 million
Allergan has paid $125 million for venture-backed Oculeve, a med-tech startup with a nerve-stimulating implant called OD-01 which is an innovative treatment for dry eye disease. Oculeve was founded by Stanford University's Michael Ackermann in 2011.